Jennifer Beam Dowd

Jennifer Beam Dowd

Auto-generated profile, based on publicly available information

Jennifer Beam Dowd

University of Oxford

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JDJennifer Beam Dowd
Jennifer Beam Dowd
LALiliana Andriano
Liliana Andriano
DBDavid M. Brazel
David M. Brazel
VRValentina Rotondi
Valentina Rotondi
PBPer Block
Per Block
MMMelinda Mills
Melinda Mills
Governments around the world must rapidly mobilize and make difficult policy decisions to mitigate the coronavirus disease 2019 (COVID-19) pandemic. Because deaths have been concentrated at older ages, we highlight the important role of demography, particularly, how the age structure of a population may help explain differences in fatality rates across countries and how transmission unfolds. We examine the role of age structure in deaths thus far in Italy and South Korea and illustrate how the pandemic could unfold in populations with similar population sizes but different age structures, showing a dramatically higher burden of mortality in countries with older versus younger populations. This powerful interaction of demography and current age-specific mortality for COVID-19 suggests that social distancing and other policies to slow transmission should consider the age composition of local and national contexts as well as intergenerational interactions. We also call for countries to provide case and fatality data disaggregated by age and sex to improve real-time targeted forecasting of hospitalization and critical care needs.

31 October 2017 in Nature Methods
Verified
Journal Article
Open access
PDF file
Edoardo PasolliEdoardo Pasolli
Edoardo Pasolli
LSLucas Schiffer
Lucas Schiffer
PMPaolo Manghi
Paolo Manghi
ARAudrey Renson
Audrey Renson
VOValerie Obenchain
Valerie Obenchain
LWLevi Waldron
Levi Waldron

4 June 2020 in Nature Human Behaviour
Verified
Journal Article
Closed access
PBPer Block
Per Block
MHMarion Hoffman
Marion Hoffman
IRIsabel J. Raabe
Isabel J. Raabe
JDJennifer Beam Dowd
Jennifer Beam Dowd
CRCharles Rahal
Charles Rahal
MMMelinda Mills
Melinda Mills

26 September 2021 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
JAJose Manuel Aburto
Jose Manuel Aburto
JSJonas Schöley
Jonas Schöley
Ilya KashnitskyIlya Kashnitsky
Ilya Kashnitsky
LZLuyin Zhang
Luyin Zhang
CRCharles Rahal
Charles Rahal
RKRidhi Kashyap
Ridhi Kashyap
Background: Variations in the age patterns and magnitudes of excess deaths, as well as differences in population sizes and age structures, make cross-national comparisons of the cumulative mortality impacts of the COVID-19 pandemic challenging. Life expectancy is a widely used indicator that provides a clear and cross-nationally comparable picture of the population-level impacts of the pandemic on mortality.Methods: Life tables by sex were calculated for 29 countries, including most European countries, Chile and the USA, for 2015–2020. Life expectancy at birth and at age 60 years for 2020 were contextualized against recent trends between 2015 and 2019. Using decomposition techniques, we examined which specific age groups contributed to reductions in life expectancy in 2020 and to what extent reductions were attributable to official COVID-19 deaths.Results: Life expectancy at birth declined from 2019 to 2020 in 27 out of 29 countries. Males in the USA and Lithuania experienced the largest losses in life expectancy at birth during 2020 (2.2 and 1.7 years, respectively), but reductions of more than an entire year were documented in 11 countries for males and 8 among females. Reductions were mostly attributable to increased mortality above age 60 years and to official COVID-19 deaths.Conclusions: The COVID-19 pandemic triggered significant mortality increases in 2020 of a magnitude not witnessed since World War II in Western Europe or the breakup of the Soviet Union in Eastern Europe. Females from 15 countries and males from 10 ended up with lower life expectancy at birth in 2020 than in 2015.

17 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAmanda M. Simanek
Amanda M. Simanek
JDJennifer Beam Dowd
Jennifer Beam Dowd
Graham PawelecGraham Pawelec
Graham Pawelec
DMDavid Melzer
David Melzer
ADAmbarish Dutta
Ambarish Dutta
AAAllison E. Aiello
Allison E. Aiello
Studies have suggested that CMV infection may influence cardiovascular disease (CVD) risk and mortality. However, there have been no large-scale examinations of these relationships among demographically diverse populations. The inflammatory marker C-reactive protein (CRP) is also linked with CVD outcomes and mortality and may play an important role in the pathway between CMV and mortality. We utilized a U.S. nationally representative study to examine whether CMV infection is associated with all-cause and CVD-related mortality. We also assessed whether CRP level mediated or modified these relationships. Data come from subjects ≥25 years of age who were tested for CMV and CRP level and were eligible for mortality follow-up on December 31st, 2006 (N = 14153) in the National Health and Nutrition Examination Survey (NHANES) III (1988–1994). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for all-cause and CVD-related mortality by CMV serostatus. After adjusting for multiple confounders, CMV seropositivity remained statistically significantly associated with all-cause mortality (HR 1.19, 95% CI: 1.01, 1.41). The association between CMV and CVD-related mortality did not achieve statistical significance after confounder adjustment. CRP did not mediate these associations. However, CMV seropositive individuals with high CRP levels showed a 30.1% higher risk for all-cause mortality and 29.5% higher risk for CVD-related mortality compared to CMV seropositive individuals with low CRP levels. CMV was associated with a significant increased risk for all-cause mortality and CMV seropositive subjects who also had high CRP levels were at substantially higher risk for both for all-cause and CVD-related mortality than subjects with low CRP levels. Future work should target the mechanisms by which CMV infection and low-level inflammation interact to yield significant impact on mortality.

2 September 2011 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
AZAnna Zajacova
Anna Zajacova
JDJennifer Beam Dowd
Jennifer Beam Dowd
General self-rated health (SRH) is widely used to study trends and inequalities in population health. Recently, there has been an increased interest in understanding the measurement properties of SRH. This study evaluated for the first time the test-retest reliability of SRH among US adults. Analyses were based on a nationally representative sample of 9,235 adults interviewed in the 2005–2008 National Health and Nutrition Examination Survey (NHANES). Respondents reported SRH on 2 occasions (about 1 month apart). Kappa statistics, polyserial correlations, and agreement tabulations were used to assess reliability across population subgroups; regression models tested the association of sociodemographic factors and the stability of the rating. Nearly 40% of respondents changed their health rating between interviews, indicating moderate test-retest reliability of SRH. Reliability differed significantly by sociodemographic characteristics: Racial/ethnic minorities and adults with less education had lower reliability of SRH judgments. Health events between interviews did not influence consistency, but conditional on a rating change, they increased the odds of downgrading one's health. The results suggest that 1) there is a substantial amount of error in individuals’ self-assessment of health and 2) reliability is worse for disadvantaged sociodemographic groups, potentially biasing estimates of health inequalities among US adults.